🇺🇸 FDA
Patent

US 11851711

DNA methylation biomarkers for cancer diagnosing

granted A61PA61P35/04

Quick answer

US patent 11851711 (DNA methylation biomarkers for cancer diagnosing) held by Arizona Board of Regents on Behalf of the University of Arizona expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arizona Board of Regents on Behalf of the University of Arizona
Grant date
Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/04